Article Information
History
- February 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gúbio Soares Campos1,
- Marta Giovanetti2,3,4,
- Laise de Moraes5,6,
- Helena Souza da Hora1,
- Keila Oliveira Motta de Alcantara1,7 and
- Silvia Ines Sardi1,*
- 1Laboratory of Virology, Health Institute of Science, Federal University of Bahia, Salvador, Bahia, Brazil
- 2Laboratório de Flavivírus, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil
- 3Department of Science and Technology for Humans and the Environment, University of Campus Bio-Medico di Roma, Rome, Italy
- 4Federal University of Minas Gerais; Belo Horizonte, Minas Gerais, Brazil
- 5Laboratório de Enfermidades Infecciosas Transmitidas por Vetores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil
- 6Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia,, Federal University of Bahia, Salvador, Bahia, Brazil
- 7Programa de Pos-graduação em Microbiologia, Instituto de Biologia, Federal University of Bahia, Salvador, Bahia, Brazil
- ↵*Corresponding author E-mail: sissardi{at}yahoo.com.br
Posted February 21, 2022.
Genomic monitoring unveils a high prevalence of SARS-CoV-2 Omicron variant in vaccine breakthrough cases
